Perbedaan Diagnos Laboratorium Utama Tbk. dan Chandra Asri Pacific Tbk.: Diagnos Laboratorium Utama Tbk. diperdagangkan di Rp224 (kapitalisasi pasar 310,75 M, volume 24 jam 963,6 rb), sedangkan Chandra Asri Pacific Tbk. diperdagangkan di Rp1.910 (kapitalisasi pasar 162,64 T, volume 24 jam 293,21 jt). Perbedaan utamanya: Chandra Asri Pacific Tbk. jauh lebih besar — sekitar 523,4× kapitalisasi pasar Diagnos Laboratorium Utama Tbk., dan Chandra Asri Pacific Tbk. lebih aktif diperdagangkan (293,21 jt vs 963,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| DGNS | TPIA | |
|---|---|---|
Kapitalisasi Pasar | 310,75 M | 162,64 T |
Volume | 963,6 rb | 293,21 jt |
Lot | 9,64 rb | 2,93 jt |
Perputaran | 217,67 jt | 565 M |
Harga Rata-rata | 225,89 | 1.926,95 |
Nilai Transaksi | 217,67 jt | 565 M |
Harga Ekuilibrium Indikatif | 226 | 1.910 |
Volume Ekuilibrium Indikatif | 1 rb | 70,47 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Selengkapnya di halaman DGNS →PT Chandra Asri Petrochemical Tbk formerly PT. Tri Polyta Indonesia, Tbk (the Company) was established under the Domestic Capital Investment Law No. 6 year 1968 and Law No. 12 year 1970 by Notarial Deed No. 40 dated November 2, 1984 of Ridwan Suselo, S.H., notary public in Jakarta. The Company is the largest Indonesia producer of polypropyleneresins that are used in the manufacture of a wide range of consumer products.
Selengkapnya di halaman TPIA →